학술논문
Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs
Document Type
Article
Author
Source
In Annals of Allergy, Asthma & Immunology 2004 93(4):360-364
Subject
Language
ISSN
1081-1206